Immunic to Participate in Investor and Scientific Conferences in August

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

Related Keywords

Canada ,New York ,United States ,Ukraine ,Quebec ,Russia ,Daniel Vitt ,Evelyn Peelen ,Paula Schwartz ,Jessica Breu ,Edna Kaplan ,Nasdaq ,Exchange Commission ,Immunic Inc ,International Congress ,Prnewswire Immunic Inc ,Rx Communications Group ,Pacgrow Healthcare ,Chief Executive Officer ,Senior Manager Translational Pharmacology ,Vidofludimus Calcium ,Orally Available ,Multiple Sclerosis ,Potently Activates ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Immunic ,Nc ,